It has been shown that MYC is overexpressed preferentially in TNBCs of the basal like subtype due to mechanisms such as copy number amplification (in ~53% of all basal-like breast cancers), changes in MYC promoter transcriptional regulation and protein stability [5, 11]. The gene discussed is MYC; the disease is breast cancer.